• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Antimicrobial resistance: time for action.抗微生物药物耐药性：行动之时
Rev Panam Salud Publica. 2020 Sep 28;44:e131. doi: 10.26633/RPSP.2020.131. eCollection 2020.
2
The effects of Japan's National Action Plan on Antimicrobial Resistance on antimicrobial use.日本国家行动计划对抗微生物药物耐药性的影响对抗微生物药物的使用的影响。
Int J Infect Dis. 2021 Feb;103:154-156. doi: 10.1016/j.ijid.2020.11.158. Epub 2020 Nov 20.
3
Barriers to implementing National Action Plans on antimicrobial resistance using a One Health Approach: policymakers' perspectives from South Africa and Eswatini.实施以“同一健康”方法为基础的国家抗菌素耐药行动计划的障碍：来自南非和斯威士兰的政策制定者的观点。
J Glob Antimicrob Resist. 2023 Jun;33:130-136. doi: 10.1016/j.jgar.2023.02.007. Epub 2023 Feb 28.
4
Outcomes and Future Prospect of Japan's National Action Plan on Antimicrobial Resistance (2016-2020).日本《抗菌药物耐药性国家行动计划（2016 - 2020年）》的成果与未来展望
Antibiotics (Basel). 2021 Oct 22;10(11):1293. doi: 10.3390/antibiotics10111293.
5
Characterizing the Mechanism of Action of an Ancient Antimicrobial, Manuka Honey, against Pseudomonas aeruginosa Using Modern Transcriptomics.利用现代转录组学表征一种古老抗菌剂麦卢卡蜂蜜对铜绿假单胞菌的作用机制
mSystems. 2020 Jun 30;5(3):e00106-20. doi: 10.1128/mSystems.00106-20.
6
Mechanisms of antimicrobial peptide action and resistance.抗菌肽的作用机制与耐药性。
Pharmacol Rev. 2003 Mar;55(1):27-55. doi: 10.1124/pr.55.1.2.
7
Control of antimicrobial resistance in Cameroon: Feasibility of implementing the National Action Plan.喀麦隆抗菌药物耐药性控制：实施国家行动计划的可行性。
Trop Med Int Health. 2021 Oct;26(10):1231-1239. doi: 10.1111/tmi.13649. Epub 2021 Jul 26.
8
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.巴基斯坦抗菌药物耐药性国家行动计划进展：叙述性综述及影响
Expert Rev Anti Infect Ther. 2022 Jan;20(1):71-93. doi: 10.1080/14787210.2021.1935238. Epub 2021 Jul 26.
9
10
The Missing Piece: Recent Approaches Investigating the Antimicrobial Mode of Action of Essential Oils.缺失的环节：研究精油抗菌作用模式的最新方法
Evol Bioinform Online. 2021 May 4;17:1176934320938391. doi: 10.1177/1176934320938391. eCollection 2021.

引用本文的文献

1
Health professional and facility engagement in antimicrobial resistance prevention and containment strategic initiatives at public hospitals in Southern Ethiopia: facility-based cross-sectional study.埃塞俄比亚南部公立医院卫生专业人员及机构参与抗菌药物耐药性预防与控制战略举措：基于机构的横断面研究
BMJ Public Health. 2025 Apr 17;3(1):e002314. doi: 10.1136/bmjph-2024-002314. eCollection 2025 Jan.
2
Promoting real-world evidence use for antimicrobial stewardship in Latin America: evaluation of impact of a two-part educational webinar series.促进拉丁美洲抗菌药物管理中真实世界证据的应用：两部分组成的教育网络研讨会系列的影响评估
JAC Antimicrob Resist. 2025 Apr 18;7(2):dlaf056. doi: 10.1093/jacamr/dlaf056. eCollection 2025 Apr.
3
Antibiotic Use in Medical-Surgical Intensive Care Units and General Wards in Latin American Hospitals.拉丁美洲医院内科-外科重症监护病房及普通病房的抗生素使用情况
Open Forum Infect Dis. 2024 Oct 11;11(11):ofae620. doi: 10.1093/ofid/ofae620. eCollection 2024 Nov.
4
Biofilm Formation, Antibiotic Resistance, and Infection (BARI): The Triangle of Death.生物膜形成、抗生素耐药性与感染（BARI）：死亡三角
J Clin Med. 2024 Sep 27;13(19):5779. doi: 10.3390/jcm13195779.
5
Characterization and antioxidant activity of nano-formulated berberine and cyperus rotundus extracts with anti-inflammatory effects in mastitis-induced rats.具有抗炎作用的纳米制剂小檗碱和香附提取物的表征及其在乳腺炎诱导大鼠中的抗氧化活性。
Sci Rep. 2024 Aug 9;14(1):18462. doi: 10.1038/s41598-024-66801-8.
6
Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.阿根廷各利益相关者在包括动物生产系统和人类在内的抗菌药物耐药性政策方面的机遇与挑战：背景与定性分析。
BMJ Open. 2024 Jun 17;14(6):e082156. doi: 10.1136/bmjopen-2023-082156.
7
Prevalence of colistin-resistant in foods and food-producing animals through the food chain: A worldwide systematic review and meta-analysis.通过食物链检测食品及产食动物中耐黏菌素情况：一项全球系统综述与荟萃分析
Heliyon. 2024 Feb 22;10(5):e26579. doi: 10.1016/j.heliyon.2024.e26579. eCollection 2024 Mar 15.
8
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.2019年美洲地区抗菌药物耐药性负担：一项跨国系统分析。
Lancet Reg Health Am. 2023 Aug 8;25:100561. doi: 10.1016/j.lana.2023.100561. eCollection 2023 Sep.
9
Drug Utilization Evaluation and Impact of Pharmacist Interventions on Optimization of Piperacillin/Tazobactam Use: A Retrospective Analysis and Prospective Audit.药物利用评估及药师干预对优化哌拉西林/他唑巴坦使用的影响：一项回顾性分析和前瞻性审计
Antibiotics (Basel). 2023 Jul 15;12(7):1192. doi: 10.3390/antibiotics12071192.
10
Epidemiology of antimicrobial resistance in bacteria isolated from inpatient and outpatient samples, Ecuador, 2018.2018年厄瓜多尔住院和门诊样本分离细菌的抗菌药物耐药性流行病学
Rev Panam Salud Publica. 2023 Apr 19;47:e14. doi: 10.26633/RPSP.2023.14. eCollection 2023.

本文引用的文献

1
Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level.巴巴多斯的耐碳青霉烯肺炎克雷伯菌：推动国家层面实践的变革
PLoS One. 2017 May 25;12(5):e0176779. doi: 10.1371/journal.pone.0176779. eCollection 2017.
2
The World Health Organization Global Action Plan for antimicrobial resistance.世界卫生组织抗微生物药物耐药性全球行动计划。
S Afr Med J. 2015 Apr 6;105(5):325. doi: 10.7196/samj.9644.
3
Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.医疗保健相关性金黄色葡萄球菌血流感染：住院时间、归因死亡率和额外的直接成本。
Braz J Infect Dis. 2012 Nov-Dec;16(6):503-9. doi: 10.1016/j.bjid.2012.10.001. Epub 2012 Nov 15.
4
Antimicrobial resistance in the age of noncommunicable diseases.非传染性疾病时代的抗菌药物耐药性。
Rev Panam Salud Publica. 2011 Dec;30(6):515-8.

Antimicrobial resistance: time for action.

作者信息

da Silva Jarbas Barbosa, Espinal Marcos, Ramón-Pardo Pilar

机构信息

Pan American Health Organization Washington, DC United States of America Pan American Health Organization, Washington, DC, United States of America.

出版信息

Rev Panam Salud Publica. 2020 Sep 28;44:e131. doi: 10.26633/RPSP.2020.131. eCollection 2020.

DOI:10.26633/RPSP.2020.131
PMID:33005187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7521182/
Abstract
摘要